Lupin Limited has informed the Exchange regarding Notice of Postal Ballot dated August 20, 2025, along with explanatory statement.
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lupin has issued a Postal Ballot Notice dated August 20, 2025, seeking shareholder approval through remote e-voting (from August 27 to September 25, 2025) for two items. The first is the re-appointment of Mr. Mark D. McDade as an Independent Director for a second 5-year term starting January 28, 2026, to January 27, 2031 — he will turn 75 during this term, which is why a Special Resolution is required. The second is a revision in the remuneration of Managing Director Mr. Nilesh D. Gupta effective October 1, 2025, for the remainder of his term ending August 31, 2028. The proposed revised pay includes a Basic Salary of ₹7.2 crore per annum, other allowances and flexi benefits of about ₹2.51 crore per annum, retirals as per company policy, and an annual performance incentive of up to 100% of fixed CTC (raised from the earlier 50% cap). Lupin justifies the revision by pointing to strong performance under Mr. Gupta — standalone revenue grew 53.9% (from ₹11,025.7 crore in FY20 to ₹16,967.5 crore in FY25) and net profit surged 446.1% (from ₹727.5 crore to ₹3,972.9 crore) — and a Deloitte peer benchmarking that places his current total pay in the bottom 10% of comparable pharma CEOs (Dr. Reddy's, Cipla, Zydus, Glenmark, Torrent, Alkem, Jubilant).
The remuneration revision modestly raises the MD's fixed pay and doubles the performance incentive ceiling, which is shareholder-friendly as it links a larger share of pay to performance, but it will increase Lupin's managerial compensation cost. Re-appointment of the Independent Director is largely procedural and signals continuity in board oversight. No major negative or positive stock catalyst is expected; results of the postal ballot will be announced by September 29, 2025.